Diode laser-assisted management of intraoral soft tissue overgrowth: a case series.


Journal

General dentistry
ISSN: 0363-6771
Titre abrégé: Gen Dent
Pays: United States
ID NLM: 7610466

Informations de publication

Date de publication:
Historique:
entrez: 30 6 2020
pubmed: 1 7 2020
medline: 17 12 2020
Statut: ppublish

Résumé

The conventional method of managing intraoral soft tissue overgrowth involves surgical excision using a scalpel under local anesthesia. These procedures are often associated with excessive bleeding that leads to complications. Now, minimally invasive methods such as laser excision are available for the management of intraoral soft tissue lesions. The objective of the present case series is to describe the use of a 980-nm diode laser to treat 4 cases of soft tissue enlargement of the oral cavity. Two women and 2 men with an age range of 21-73 years presented with chief complaints of intraoral swelling. The overgrowth was located on the tongue in 2 patients and in the gingival region in 2 patients. In all 4 patients, the overgrown tissues were excised with a 980-nm gallium-arsenide diode laser at a power of 1.0-4.0 W in continuous-wave contact mode. Excised tissues were sent for histopathologic examination to confirm the clinical diagnosis. Each lesion was excised with adequate hemostasis in 15-20 minutes. At the recall examination after 10 days, patients did not report any postoperative complications. There was no sign of recurrence in any patient at the 3-month follow-up. Based on the histopathologic reports, 2 lesions were diagnosed as pyogenic granuloma, 1 as capillary hemangioma (a form of pyogenic granuloma), and 1 as peripheral ossifying fibroma. The results of this limited case series suggest that a 980-nm diode laser may be an advantageous surgical modality for treating benign proliferative lesions of the oral mucosa with negligible postoperative adverse sequelae.

Identifiants

pubmed: 32597774

Types de publication

Case Reports Journal Article

Langues

eng

Pagination

28-31

Déclaration de conflit d'intérêts

The authors report no conflicts of interest pertaining to any of the products or companies discussed in this article.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH